Literature DB >> 24981439

Nano-polypharmacy to treat tumors: coencapsulation of drug combinations using nanoparticle technology.

Frank Alexis1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24981439      PMCID： PMC4088995          DOI： 10.1038/mt.2014.96

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  23 in total

Review 1.  Strategies for optimizing combinations of molecularly targeted anticancer agents.

Authors:  Janet E Dancey; Helen X Chen
Journal:  Nat Rev Drug Discov       Date:  2006-08       Impact factor: 84.694

Review 2.  Mechanisms of drug combinations: interaction and network perspectives.

Authors:  Jia Jia; Feng Zhu; Xiaohua Ma; Zhiwei Cao; Zhiwei W Cao; Yixue Li; Yixue X Li; Yu Zong Chen
Journal:  Nat Rev Drug Discov       Date:  2009-02       Impact factor: 84.694

Review 3.  Regulatory perspective on the importance of ADME assessment of nanoscale material containing drugs.

Authors:  Banu S Zolnik; Nakissa Sadrieh
Journal:  Adv Drug Deliv Rev       Date:  2009-04-20       Impact factor: 15.470

4.  Nanotechnology for drug delivery: the perfect partnership.

Authors:  Omid C Farokhzad
Journal:  Expert Opin Drug Deliv       Date:  2008-09       Impact factor: 6.648

Review 5.  Personalized medicine in oncology: the future is now.

Authors:  Richard L Schilsky
Journal:  Nat Rev Drug Discov       Date:  2010-05       Impact factor: 84.694

Review 6.  Current development of mTOR inhibitors as anticancer agents.

Authors:  Sandrine Faivre; Guido Kroemer; Eric Raymond
Journal:  Nat Rev Drug Discov       Date:  2006-08       Impact factor: 84.694

Review 7.  Factors affecting the clearance and biodistribution of polymeric nanoparticles.

Authors:  Frank Alexis; Eric Pridgen; Linda K Molnar; Omid C Farokhzad
Journal:  Mol Pharm       Date:  2008-08-04       Impact factor: 4.939

8.  Application of nanotechnology in cancer therapy and imaging.

Authors:  Xu Wang; Lily Yang; Zhuo Georgia Chen; Dong M Shin
Journal:  CA Cancer J Clin       Date:  2008-01-28       Impact factor: 508.702

Review 9.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

Review 10.  Nanoparticle therapeutics: an emerging treatment modality for cancer.

Authors:  Mark E Davis; Zhuo Georgia Chen; Dong M Shin
Journal:  Nat Rev Drug Discov       Date:  2008-09       Impact factor: 84.694
View more
  5 in total

Review 1.  Polymeric Nanostructures for Imaging and Therapy.

Authors:  Mahmoud Elsabahy; Gyu Seong Heo; Soon-Mi Lim; Guorong Sun; Karen L Wooley
Journal:  Chem Rev       Date:  2015-08-04       Impact factor: 60.622

2.  Clinical Cancer Nanomedicine.

Authors:  Joy Wolfram; Mauro Ferrari
Journal:  Nano Today       Date:  2019-03-06       Impact factor: 20.722

3.  Dual Encapsulated Dacarbazine and Zinc Phthalocyanine Polymeric Nanoparticle for Photodynamic Therapy of Melanoma.

Authors:  Sara Rhaissa Rezende do Reis; Edward Helal-Neto; Aline Oliveira da Silva de Barros; Suyene Rocha Pinto; Filipe Leal Portilho; Luciana Betzler de Oliveira Siqueira; Luciana Magalhães Rebelo Alencar; Si Amar Dahoumane; Frank Alexis; Eduardo Ricci-Junior; Ralph Santos-Oliveira
Journal:  Pharm Res       Date:  2021-02-18       Impact factor: 4.200

Review 4.  Pathobiology and Therapeutic Relevance of GSK-3 in Chronic Hematological Malignancies.

Authors:  Alberto M Martelli; Francesca Paganelli; Camilla Evangelisti; Francesca Chiarini; James A McCubrey
Journal:  Cells       Date:  2022-05-31       Impact factor: 7.666

5.  Role of anti-stromal polypharmacy in increasing survival after pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.

Authors:  Samuel J Tingle; John A Moir; Steven A White
Journal:  World J Gastrointest Pathophysiol       Date:  2015-11-15
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.